Efficacy of ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam combinations against carbapenemase-producing Enterobacterales in Switzerland

Carbapenemase-producing in Enterobacterales (CPE) represent a critical health concern worldwide, including in Switzerland, leading to very limited therapeutic options. Therefore, our aim was to evaluate the susceptibility to the novel ß-lactam/ß-lactamase inhibitor combinations ceftazidime-avibactam...

Descripción completa

Detalles Bibliográficos
Autores principales: Nordmann, Patrice, Bouvier, Maxime, Poirel, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427697/
https://www.ncbi.nlm.nih.gov/pubmed/37566365
http://dx.doi.org/10.1007/s10096-023-04647-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427697/
https://www.ncbi.nlm.nih.gov/pubmed/37566365
http://dx.doi.org/10.1007/s10096-023-04647-0

Ejemplares similares